CGTX Cognition Therapeutics, Inc.

NASDAQ
$0.60

Cognition Therapeutics, Inc. (CGTX) Earnings News

Earnings press releases, previews and reviews for Cognition Therapeutics, Inc. (CGTX), newest first. Our most recent is review: Cognition Therapeutics Narrows Loss and Lands FDA Alignment on a Leaner DLB Phase 3, but the Pivotal Trial Is Still Unfunded.